Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex MacKenzie

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Clinical and Translational Science|May 27, 2015
Sodium Channel Inhibitors Reduce DMPK mRNA and ProteinLuke Witherspoon, Sean O'Reilly, Jeremiah Hadwen, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Human Growth Hormone Increases SMN Expression and Survival in Severe Spinal Muscular Atrophy Mouse ModelDuncan MacKenzie, Fahad Shamim, Kevin Mongeon, et al.
Clinical and Translational Science|June 8, 2018
Anisomycin Activates Utrophin Upregulation Through a p38 Signaling PathwayJeremiah Hadwen, Faraz Farooq, Luke Witherspoon, et al.
Molecular Endocrinology (Baltimore, Md.)|September 29, 2007
Estrogen suppresses uterine epithelial apoptosis by inducing birc1 expressionYan Yin, Wei-Wei Huang, Congxing Lin, et al.
The International Journal of Biochemistry & Cell Biology|February 23, 2010
Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9Jamshid Davoodi, Mohammad-Hossein Ghahremani, Ali Es-Haghi, et al.
Orphanet Journal of Rare Diseases|January 11, 2014
VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse modelsJeremiah Hadwen, Duncan MacKenzie, Fahad Shamim, et al.
Scientific Reports|January 7, 2017
Neuronal apoptosis inhibitory protein (NAIP) localizes to the cytokinetic machinery during cell divisionFrancisco Abadía-Molina, Virginia Morón-Calvente, Stephen D Baird, et al.
Journal of Neuromuscular Diseases|May 22, 2025
Systematic review for economic evaluations on newborn screening for spinal muscular atrophyAlexander C Pace, Corrina Poon, Pranesh Chakraborty, et al.
Human Molecular Genetics|June 15, 2018
Transcriptomic RNAseq drug screen in cerebrocortical cultures: toward novel neurogenetic disease therapiesJeremiah Hadwen, Sarah Schock, Alan Mears, et al.
The Journal of Clinical Investigation|July 26, 2011
Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathwayFaraz Farooq, Francisco Abadía Molina, Jeremiah Hadwen, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Clinical and Translational Science|May 27, 2015
Sodium Channel Inhibitors Reduce DMPK mRNA and ProteinLuke Witherspoon, Sean O'Reilly, Jeremiah Hadwen, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Human Growth Hormone Increases SMN Expression and Survival in Severe Spinal Muscular Atrophy Mouse ModelDuncan MacKenzie, Fahad Shamim, Kevin Mongeon, et al.
Clinical and Translational Science|June 8, 2018
Anisomycin Activates Utrophin Upregulation Through a p38 Signaling PathwayJeremiah Hadwen, Faraz Farooq, Luke Witherspoon, et al.
Molecular Endocrinology (Baltimore, Md.)|September 29, 2007
Estrogen suppresses uterine epithelial apoptosis by inducing birc1 expressionYan Yin, Wei-Wei Huang, Congxing Lin, et al.
The International Journal of Biochemistry & Cell Biology|February 23, 2010
Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9Jamshid Davoodi, Mohammad-Hossein Ghahremani, Ali Es-Haghi, et al.
Orphanet Journal of Rare Diseases|January 11, 2014
VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse modelsJeremiah Hadwen, Duncan MacKenzie, Fahad Shamim, et al.
Scientific Reports|January 7, 2017
Neuronal apoptosis inhibitory protein (NAIP) localizes to the cytokinetic machinery during cell divisionFrancisco Abadía-Molina, Virginia Morón-Calvente, Stephen D Baird, et al.
Journal of Neuromuscular Diseases|May 22, 2025
Systematic review for economic evaluations on newborn screening for spinal muscular atrophyAlexander C Pace, Corrina Poon, Pranesh Chakraborty, et al.
Human Molecular Genetics|June 15, 2018
Transcriptomic RNAseq drug screen in cerebrocortical cultures: toward novel neurogenetic disease therapiesJeremiah Hadwen, Sarah Schock, Alan Mears, et al.
The Journal of Clinical Investigation|July 26, 2011
Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathwayFaraz Farooq, Francisco Abadía Molina, Jeremiah Hadwen, et al.
Pageof 5